Denise Ragusa

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Gene Expression

Genome Wide Identification

Top Venues

Scientific reports

International journal of molecular sciences

Bioscience reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Elisa Garimberti, Concetta Federico, Denise Ragusa, Francesca Bruno, Salvatore Saccone, Joanna Mary Bridger, Sabrina Tosi
Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation. International journal of molecular sciences 25 (4) (2024)
Elisa Garimberti, Concetta Federico, Denise Ragusa, Francesca Bruno, Salvatore Saccone, Joanna Mary Bridger, Sabrina Tosi
Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation. International journal of molecular sciences 25 (4) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Elisa Garimberti, Concetta Federico, Denise Ragusa, Francesca Bruno, Salvatore Saccone, Joanna Mary Bridger, Sabrina Tosi
Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation. International journal of molecular sciences 25 (4) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Denise Ragusa, Liza Dijkhuis, Cristina Pina, Sabrina Tosi
Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. Bioscience reports 43 (1) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Liza Dijkhuis, Ayona Johns, Denise Ragusa, Susanne C van den Brink, Cristina Pina
Haematopoietic development and HSC formation in vitro: promise and limitations of gastruloid models. Emerging topics in life sciences (2023)
Denise Ragusa, Liza Dijkhuis, Cristina Pina, Sabrina Tosi
Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. Bioscience reports 43 (1) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Denise Ragusa, Liza Dijkhuis, Cristina Pina, Sabrina Tosi
Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. Bioscience reports 43 (1) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Denise Ragusa, Ylenia Cicirò, Concetta Federico, Salvatore Saccone, Francesca Bruno, Reza Saeedi, Cristina Sisu, Cristina Pina, Arturo Sala, Sabrina Tosi
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles. Oncogenesis 11 (1) (2022)
Denise Ragusa, Sabrina Tosi, Cristina Sisu
Pan-Cancer Analysis Identifies MNX1 and Associated Antisense Transcripts as Biomarkers for Cancer. Cells 11 (22) (2022)
Concetta Federico, Francesca Bruno, Denise Ragusa, Craig S Clements, Desiree Brancato, Marianne P Henry, Joanna M Bridger, Sabrina Tosi, Salvatore Saccone
Chromosomal Rearrangements and Altered Nuclear Organization: Recent Mechanistic Models in Cancer. Cancers 13 (22) (2021)
Gesualda M Gulino, Francesca Bruno, Valentina Sturiale, Desiree Brancato, Denise Ragusa, Sabrina Tosi, Salvatore Saccone, Concetta Federico
From FISH to Hi-C: The Chromatin Architecture of the Chromosomal Region 7q36.3, Frequently Rearranged in Leukemic Cells, Is Evolutionary Conserved. International journal of molecular sciences 22 (5) (2021)
Denise Ragusa, Evgeny M Makarov, Oliver Britten, Daniela Moralli, Catherine M Green, Sabrina Tosi
The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features. Cancer reports (Hoboken, N.J.) 2 (5) (2019)